Scott D. Grimes - 16 Jul 2021 Form 4 Insider Report for Cardlytics, Inc. (CDLX)

Role
Director
Signature
/s/ Kirk Somers, Attorney-in-Fact
Issuer symbol
CDLX
Transactions as of
16 Jul 2021
Net transactions value
-$601,770
Form type
4
Filing time
20 Jul 2021, 16:55:49 UTC
Previous filing
06 Jul 2021
Next filing
27 Jul 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CDLX Common Stock Sale $83,634 -682 -0.91% $122.63* 74,430 16 Jul 2021 See Footnote F1, F2, F3
transaction CDLX Common Stock Sale $36,755 -298 -0.4% $123.34* 74,132 16 Jul 2021 See Footnote F1, F3, F4
transaction CDLX Common Stock Sale $25,032 -200 -0.27% $125.16* 73,932 16 Jul 2021 See Footnote F1, F3, F5
transaction CDLX Common Stock Sale $78,436 -620 -0.84% $126.51* 73,312 16 Jul 2021 See Footnote F1, F3, F6
transaction CDLX Common Stock Sale $25,478 -200 -0.27% $127.39* 73,112 16 Jul 2021 See Footnote F1, F3, F7
transaction CDLX Common Stock Sale $116,670 -1,000 -0.42% $116.67* 239,674 19 Jul 2021 Direct F8, F9
transaction CDLX Common Stock Sale $199,366 -1,695 -0.71% $117.62* 237,979 19 Jul 2021 Direct F8, F10
transaction CDLX Common Stock Sale $24,352 -205 -0.09% $118.79* 237,774 19 Jul 2021 Direct F8, F11
transaction CDLX Common Stock Sale $12,047 -100 -0.04% $120.47* 237,674 19 Jul 2021 Direct F8
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the trustee of the 2013 Scott Grimes GRAT UAD (the "GRAT") on November 15, 2019, as amended March 12, 2020.
F2 The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $122.19 to $123.11, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (4), (5), (6), (7), (9), (10) and (11) to this Form 4.
F3 The reportable securities are held by the GRAT.
F4 The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $123.24 to $123.39, inclusive.
F5 The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $124.76 to $125.55, inclusive.
F6 The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $125.99 to $126.84, inclusive.
F7 The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $127.12 to $127.65, inclusive.
F8 These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 12, 2020.
F9 The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $116.07 to $117.05, inclusive.
F10 The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $117.08 to $118.05, inclusive.
F11 The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $118.31 to $119.28, inclusive.